Customer Guest
please type the captcha code.
Register|Generate Password|Dos and Don'ts of Demat Account
For Login related queries e-mail: emkayassist@emkayglobal.com
"Attention Investors
1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. 6.Investor Charter 7.Disclosure of Complaints 8.COMPLAINTS / SCORES 9. Verify Nomination in Account, click on link (:: Central Depository Services (India) Limited :: )
.......... Issued in the interest of Investors"
Regenerate OTP
Please contact to emkayassist@emkayglobal.com
Please select Mobile No and Email Id for OTP
Login | Register
Login | Register|Forgot password?
Natco Pharma Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substan...more...
As of March 2026 49.42% is owned by Promoters and 50.58% by Public. Among Promoters holding Indian Promoters holds 49.14% and Foreign Promot...more...
Natco Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations 2018more...
Compliance Certificates under Regulation 74(5) of SEBI (DP) Regulation 2018more...
Natco Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015more...
E-voting Results of Postal Ballot Resultsmore...
Natco Pharma Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further the company has informed the Exchange regarding v...more...
Outcome of the Board Meeting for incorporation of subsidiary Company in Nigeriamore...
Outcome of Board Meetingmore...
Outcome of the Board Meeting held on 24th March 2026more...
Natco Pharma Limited has informed the Exchange regarding Outcome of Board Meeting held on March 24 2026more...
NATCO Pharma has announced the launch of its generic Semaglutide injection in India marking its entry on Day 1 of patent expiry. The company...more...
NATCO Pharma Limited launches Semaglutide Generic Injection Multi Dose Vials in India at the Most Affordable Price starting from MRP INR 1290/-more...
Natco Pharma Limited has informed the Exchange regarding a press release dated March 20 2026 titled NATCO Pharma Launches Semaglutide Generi...more...
Investor Meetmore...
Natco Pharma Limited has informed the Exchange about Schedule of meetmore...
Natco announces launch of Pomalidomide Capsules (generci of Pomalyst) in the U.S. marketmore...
Natco Pharma Limited has informed the Exchange regarding a press release dated March 03 2026 titled NATCO announces launch of Pomalidomide C...more...
Clarification on volume Movement of Sharesmore...
The Exchange has sought clarification from Natco Pharma Ltd on February 25 2026 with reference to Movement in Volume. The reply is awaited.more...
BOARD MEETINGS Company Name : Abhinav Cap. Serv. Date : 14-05-2026